← Evidence map

ArticleJCI insight2025

Piperlongumine overcomes osimertinib resistance via governing ubiquitination-modulated Sp1 turnover.

Ruirui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40125551